A new trading day began on Monday, with 89bio Inc (NASDAQ: ETNB) stock price down -8.41% from the previous day of trading, before settling in for the closing price of $11.06. ETNB’s price has ranged from $5.99 to $16.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -59.99%. With a float of $138.72 million, this company’s outstanding shares have now reached $145.75 million.
In an organization with 70 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 84.19%, operating margin of -129853.42%, and the pretax margin is -121648.72%.
89bio Inc (ETNB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of 89bio Inc is 4.82%, while institutional ownership is 90.00%. The most recent insider transaction that took place on Jan 30 ’25, was worth 49,999,994. In this transaction Director of this company bought 5,714,285 shares at a rate of $8.75, taking the stock ownership to the 19,554,319 shares. Before that another transaction happened on Jan 22 ’25, when Company’s Director bought 10,000 for $6.71, making the entire transaction worth $67,100. This insider now owns 25,000 shares in total.
89bio Inc (ETNB) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -59.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -10.60% during the next five years compared to -11.24% drop over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Here are 89bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.91, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.59 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
Let’s dig in a bit further. During the last 5-days, its volume was 1.26 million. That was inferior than the volume of 2.72 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 29.19%. Additionally, its Average True Range was 0.71.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 70.79%, which indicates a significant increase from 30.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.53% in the past 14 days, which was higher than the 80.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.61, while its 200-day Moving Average is $8.46. However, in the short run, 89bio Inc’s stock first resistance to watch stands at $10.84. Second resistance stands at $11.54. The third major resistance level sits at $11.91. If the price goes on to break the first support level at $9.76, it is likely to go to the next support level at $9.39. Assuming the price breaks the second support level, the third support level stands at $8.69.
89bio Inc (NASDAQ: ETNB) Key Stats
With a market capitalization of 1.48 billion, the company has a total of 106,126K Shares Outstanding. Currently, annual sales are 0 K while annual income is -142,190 K. The company’s previous quarter sales were 0 K while its latest quarter income was -149,070 K.
